Sstr4 Agonist Salts

Abstract: The present invention relates to specific salts of (1S,5R)-(1a,5a,6a)-N-[1,1-dimethyl-2-[(3-methyl-2-pyridyl)oxy]ethyl]-3-azabicyclo[3.1.0]hexane-6-carboxamide, to pharmaceutical compositions comprising said salts, to methods of using said salts to treat physiological disorders, and to intermediates useful in the synthesis of the salts.

Patent Information

Application #

Filing Date

14 March 2024

Publication Number

44/2024

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

ELI LILLY AND COMPANY

Lilly Corporate Center Indianapolis, Indiana 46285

Inventors

1. COATES, David Andrew

c/o Eli Lilly And Company P.O. Box 6288 Indianapolis, Indiana 46206-6288

2. REMICK, David Michael

c/o Eli Lilly And Company P.O. Box 6288 Indianapolis, Indiana 46206-6288

Specification

Documents

Application Documents

#	Name	Date
1	202417018446-STATEMENT OF UNDERTAKING (FORM 3) [14-03-2024(online)].pdf	2024-03-14
2	202417018446-REQUEST FOR EXAMINATION (FORM-18) [14-03-2024(online)].pdf	2024-03-14
3	202417018446-PRIORITY DOCUMENTS [14-03-2024(online)].pdf	2024-03-14
4	202417018446-POWER OF AUTHORITY [14-03-2024(online)].pdf	2024-03-14
5	202417018446-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [14-03-2024(online)].pdf	2024-03-14
6	202417018446-FORM 18 [14-03-2024(online)].pdf	2024-03-14
7	202417018446-FORM 1 [14-03-2024(online)].pdf	2024-03-14
8	202417018446-FIGURE OF ABSTRACT [14-03-2024(online)].pdf	2024-03-14
9	202417018446-DECLARATION OF INVENTORSHIP (FORM 5) [14-03-2024(online)].pdf	2024-03-14
10	202417018446-COMPLETE SPECIFICATION [14-03-2024(online)].pdf	2024-03-14
11	202417018446-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [14-03-2024(online)].pdf	2024-03-14
12	202417018446-FORM 3 [15-05-2024(online)].pdf	2024-05-15
13	202417018446-Proof of Right [23-07-2024(online)].pdf	2024-07-23